Why Bill Ackman Bet $2.3 Billion That the Market Is Dead Wrong
In early 2025, billionaire investor Bill Ackman, CEO of Pershing Square Capital Management, revealed a substantial new position in Uber Technologies. By January, Pershing Square had accumulated 30.3 million Uber shares, a ~1.4% stake worth about $2.3 billion.
Ackman described Uber as “one of the best-managed and highest-quality businesses in the world,” yet still “available at a massive discount to its intrinsic value.”
So is he right about Uber or will the bet flop?
» Read more about: Why Bill Ackman Bet $2.3 Billion That the Market Is Dead Wrong »
Read More
Market Commentary: Up 193% So Far, Can This Quantum Stock Soar Higher?
Back in 2015, a team of engineers from the University of Maryland came together with an idea to develop and manufacture quantum computers which can be used to solve a variety of problems that are currently intractable with classical computers, such as…
Read More
Market Commentary: Shocking 2030 Trend Will Make Millionaires
What percentage of the US population is obese? Go on, hazard a guess. What do you think the figure is without looking it up?
According to Healthline, a little over 42% of the US population is clinically obese. And that figure is expected to balloon to 50% by 2030.
Read More
Market Commentary: The Perfect Portfolio Revealed
Picking stocks is hard enough but how do you decide what amount to allocate to each stock? Portfolio construction is an art unto itself. Done well, a portfolio can withstand economic storms. Done poorly, the results can be catastrophic.
For two contrasting perspectives, look no further than Berkshire Hathaway versus ARK Invest during 2022.
» Read more about: Market Commentary: The Perfect Portfolio Revealed »
Read More
1 Under-the-Radar Pharma Stock with 90% Upside?
Billionaire Stanley Druckenmiller has been making large changes to his portfolio recently, leaving retail investors struggling to keep up with what the famous stock picker is thinking.
One of the smaller holdings in Druckenmiller’s portfolio that makes for interesting examination is ARS Pharmaceuticals (NASDAQ:SPRY).
Druckenmiller’s 536,900 shares of SPRY are currently valued at around $7 million.
» Read more about: 1 Under-the-Radar Pharma Stock with 90% Upside? »
Read MoreThe Ivy
Will This Tiny Quantum Stock 2x by 2030?
IonQ isn’t a household name yet. But give it time. This small-cap quantum computing company is pulling in some big-league attention and the numbers from early 2025 are starting to back it up.
You’re probably used to hearing about quantum computing like it’s some distant dream but in Q1 2025, that revenue hit $7.6 million.
» Read more about: Will This Tiny Quantum Stock 2x by 2030? »
Read MoreThe Spotlight
Will This $20 Million Bet Pay Off?
A report just came out that one trader bet a massive $20 million on a single stock rising by 30% on its next earnings report. That stock is, drumroll, artificial intelligence favorite, Nvidia.
The bet was made by purchasing strike 1180 call options on Nvidia for the June expiration, meaning if NVDA share price rise were to rise above that level on expiration day,
» Read more about: Will This $20 Million Bet Pay Off? »
Read MoreThe Daily
Why Shares of FuelCell Energy Are Skyrocketing Today
Key Points
-
FuelCell Energy reported fourth-quarter 2025 financial results.
-
The company beat analysts’
» Read more about: Why Shares of FuelCell Energy Are Skyrocketing Today »